Exact Mass: 487.34098900000004

Exact Mass Matches: 487.34098900000004

Found 340 metabolites which its exact mass value is equals to given mass value 487.34098900000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(4Z,7Z,10Z,13Z,15E,19Z)-17-Hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine

3-[(17-hydroxydocosa-4,7,10,13,15,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,11Z,13Z,16Z,19Z)-10-Hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine

3-[(10-hydroxydocosa-4,7,11,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,11Z,13Z,16Z,19Z)-10-hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7E,9E,13Z,16Z,19Z)-11-Hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine

3-[(11-hydroxydocosa-4,7,9,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7E,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,14E,16Z,19Z)-13-Hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine

3-[(13-hydroxydocosa-4,7,10,14,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z,17Z,19Z)-16-Hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine

3-[(16-hydroxydocosa-4,7,10,13,17,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,17Z,19Z)-16-hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z,16E,18E)-20-Hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine

3-[(20-hydroxydocosa-4,7,10,13,16,18-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,16E,18E)-20-hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(5Z,7Z,10Z,13Z,16Z,19Z)-4-Hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine

3-[(4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,8Z,10Z,13Z,16Z,19Z)-7-Hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine

3-[(7-hydroxydocosa-4,8,10,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4E,6E,10Z,13Z,16Z,19Z)-8-Hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine

3-[(8-hydroxydocosa-4,6,10,13,16,19-hexaenoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine is an acylcarnitine. More specifically, it is an (4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4E,6E,10Z,13Z,16Z,19Z)-8-hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z,16Z)-18-(3-Ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine

3-{[18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoyl]oxy}-4-(trimethylazaniumyl)butanoate

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-Pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine

3-({15-[3-(pent-2-en-1-yl)oxiran-2-yl]pentadeca-4,7,10,13-tetraenoyl}oxy)-4-(trimethylazaniumyl)butanoic acid

C29H45NO5 (487.32975600000003)


(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Talaroconvolutin A

Talaroconvolutin A

C32H41NO3 (487.3086276)


An octahydronaphthalene with formula C32H41NO3. It is a fungal metabolite isolated from Talaromyces convolutus and is an inducer of ferroptosis in colorectal cancer cells.

   

Sulpinine B

Sulpinine B

C32H41NO3 (487.3086276)


   

Beauveriolide III

Beauveriolide III

C27H41N3O5 (487.30460560000006)


   

SCHEMBL16431315

SCHEMBL16431315

C25H45NO8 (487.314501)


   

Calyciphylline P

Calyciphylline P

C30H49NO4 (487.36613940000007)


   

C28H49N5O2

C28H49N5O2 (487.3886054)


   

Beauverolide H

Beauverolide H

C27H41N3O5 (487.30460560000006)


   

Kimbasine A

Kimbasine A

C29H45NO5 (487.32975600000003)


   

Batzelladine L|beauveriolide I|beauverolide I

Batzelladine L|beauveriolide I|beauverolide I

C27H41N3O5 (487.30460560000006)


   

Ambruticin VS 4

Ambruticin VS 4

C29H45NO5 (487.32975600000003)


   

C29H45NO5

C29H45NO5 (487.32975600000003)


   

C31H41N3O2

C31H41N3O2 (487.3198606)


   

Oteromycin

Oteromycin

C32H41NO3 (487.3086276)


   

3-(3-methylcrotonyl)cassain

3-(3-methylcrotonyl)cassain

C29H45NO5 (487.32975600000003)


   

Cordycepeptide A

Cordycepeptide A

C27H41N3O5 (487.30460560000006)


   

23-O-Acetyl-12beta-hydroxy-solasodin

23-O-Acetyl-12beta-hydroxy-solasodin

C29H45NO5 (487.32975600000003)


   

Piericidin D4

Piericidin D4

C29H45NO5 (487.32975600000003)


   

Asn Val Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]hexanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Asn Lys Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]-3-methylbutanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Ile Val Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Beauverolide I

Beauverolide I

C27H41N3O5 (487.30460560000006)


   

Asp Ile Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Ile Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Ile Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Ile Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-4-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Lys Leu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-4-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Asp Leu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Ile Lys Val

(4S)-4-amino-4-{[(1S,2S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Ile Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylpentanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Ile Val

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-methylbutyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Leu Val

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-3-methylbutyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Lys Val Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Leu Lys Val

(4S)-4-amino-4-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Leu Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-methylpentanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Glu Val Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Gly Lys Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanamido]-5-carbamimidamidopentanoic acid

C20H41N9O5 (487.32304960000005)


   

Gly Lys Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-5-carbamimidamidopentanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Gly Arg Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]hexanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Ile Asp Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Asp Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Asp Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Asp Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Glu Lys Val

(4S)-4-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-4-[(2S,3S)-2-amino-3-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Glu Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carboxybutanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Ile Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Ile Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Ile Arg Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ile Ser Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Lys Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Asp Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Glu Val

(4S)-4-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Leu Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Lys Val Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Leu Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Leu Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Leu Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Leu Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Arg Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Ser Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Thr Arg Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Thr Val Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Val Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Ile Val Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Ile Val Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Ile Val Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Asp Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Asp Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Asp Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Asp Leu Leu

(2S)-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Ile Val

(4S)-4-{[(1S,2S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-methylbutyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Leu Val

(4S)-4-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-3-methylbutyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-4-carboxy-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Glu Val Leu

(2S)-2-[(2S)-2-[(2S)-4-carboxy-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Gly Lys Arg

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanamido]-5-carbamimidamidopentanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Gly Arg Lys

(2S)-6-amino-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}pentanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Ile Asp Ile

(2S,3S)-2-[(2S)-3-carboxy-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Asp Leu

(2S)-2-[(2S)-3-carboxy-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Glu Val

(4S)-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-4-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Ile Asp

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Leu Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Ile Val Glu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Lys Gly Arg

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetamido}-5-carbamimidamidopentanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Lys Asn Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Lys Arg Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-5-carbamimidamidopentanamido]acetic acid

C20H41N9O5 (487.32304960000005)


   

Lys Lys Val Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Leu Asp Ile

(2S,3S)-2-[(2S)-3-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Asp Leu

(2S)-2-[(2S)-3-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Glu Val

(4S)-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-4-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Leu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Leu Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Asn Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]hexanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Asn Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylbutanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Arg Gly Lys

(2S)-6-amino-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]acetamido}hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Lys Arg Lys Gly

2-[(2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]hexanamido]acetic acid

C20H41N9O5 (487.32304960000005)


   

Lys Val Glu Ile

(2S,3S)-2-[(2S)-4-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]butanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Glu Leu

(2S)-2-[(2S)-4-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]butanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]hexanamido]-3-carbamoylpropanoic acid

C21H41N7O6 (487.31181660000004)


   

Lys Val Leu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-4-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Lys Val Asn Lys

(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]propanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Asp Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Asp Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Asp Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Asp Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Glu Lys Val

(4S)-4-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pentyl]carbamoyl}-4-[(2S)-2-amino-4-methylpentanamido]butanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Glu Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carboxybutanamido]-3-methylbutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Ile Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Ile Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Ile Arg Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ile Ser Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Lys Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Asp Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Glu Val

(4S)-4-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Leu Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-methylpentanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Lys Val Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylbutanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Leu Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-carboxypropanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Leu Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]hexanamido]butanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Leu Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Leu Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Arg Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Ser Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Thr Arg Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Thr Val Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Val Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Leu Val Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Leu Val Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Leu Val Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Asn Lys Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]hexanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}hexanamido]hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Arg Ile Ile Ser

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Leu Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Ser Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Ser Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Thr Val

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ile Val Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]acetamido}hexanoic acid

C20H41N9O5 (487.32304960000005)


   

Arg Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]hexanamido]acetic acid

C20H41N9O5 (487.32304960000005)


   

Arg Leu Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Leu Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ser Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ser Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ser Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Ser Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Ile Val

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Leu Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Val Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Thr Val Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Arg Val Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Ile Arg

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Leu Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Arg Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Ile Arg Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Leu Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Ser Arg Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Ile Arg Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Leu Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Leu Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Arg Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Thr Val Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Glu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]-3-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Glu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]hexanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Glu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]hexanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Glu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]-4-methylpentanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Ile Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Ile Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Ile Arg Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Ile Thr Arg

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Lys Glu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-carboxybutanamido]-3-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Glu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-carboxybutanamido]-4-methylpentanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]hexanamido]-3-carbamoylpropanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Lys Leu Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-methylpentanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Lys Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-carbamoylpropanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Leu Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-4-carboxybutanamido]hexanoic acid

C22H41N5O7 (487.30058360000004)


   

Val Leu Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]hexanamido]pentanedioic acid

C22H41N5O7 (487.30058360000004)


   

Val Leu Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Leu Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Asn Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]hexanamido]hexanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Arg Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Ile Arg

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Leu Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Arg Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

Val Thr Arg Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C21H41N7O6 (487.31181660000004)


   

(Z)-2-pentacos-16-enamidoethanesulfonic acid

(Z)-2-pentacos-16-enamidoethanesulfonic acid

C27H53NO4S (487.36950980000006)


   

2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phosphoethanolamine

2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phosphoethanolamine

C25H46NO6P (487.30625860000004)


   

LPE O-20:4

2-(8-[3]-ladderane-octanyl)-sn-glycero-3-phosphoethanolamine

C25H46NO6P (487.30625860000004)


   

Poly(oxy-1,2-ethanediyl), .alpha.-sulfo- .omega.-(dinonylphenoxy)-, ammonium salt

Poly(oxy-1,2-ethanediyl), .alpha.-sulfo- .omega.-(dinonylphenoxy)-, ammonium salt

C26H49NO5S (487.3331264000001)


   

1-Octanaminium,N-[2-[(2,2-dicyclopentylacetyl)oxy]ethyl]-N,N-diethyl-, bromide (1:1)

1-Octanaminium,N-[2-[(2,2-dicyclopentylacetyl)oxy]ethyl]-N,N-diethyl-, bromide (1:1)

C26H50BrNO2 (487.30247)


   

Beauveriolide I

Beauveriolide I

C27H41N3O5 (487.30460560000006)


A cyclodepsipeptide with formula C27H41N3O5. It was originally isolated from the fungus Beauveria sp. FO-6979 during a screening program for inhibitors of lipid droplet accumulation in murine macrophages. It is an inhibitor of acyl-CoA: cholesterol acyltransferase (ACAT) and effective at reducing atherogenic lesions of the artery and heart in mouse models.

   

Desacetylrocuronium

Desacetylrocuronium

C30H51N2O3+ (487.3899476)


   

Beauveriolide-I; SCH-58149

Beauveriolide-I; SCH-58149

C27H41N3O5 (487.30460560000006)


   

(4Z,7Z,10Z,13Z,15E,19Z)-17-Hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine

(4Z,7Z,10Z,13Z,15E,19Z)-17-Hydroxydocosa-4,7,10,13,15,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,11Z,13Z,16Z,19Z)-10-Hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine

(4Z,7Z,11Z,13Z,16Z,19Z)-10-Hydroxydocosa-4,7,11,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7E,9E,13Z,16Z,19Z)-11-Hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine

(4Z,7E,9E,13Z,16Z,19Z)-11-Hydroxydocosa-4,7,9,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,14E,16Z,19Z)-13-Hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine

(4Z,7Z,10Z,14E,16Z,19Z)-13-Hydroxydocosa-4,7,10,14,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z,17Z,19Z)-16-Hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine

(4Z,7Z,10Z,13Z,17Z,19Z)-16-Hydroxydocosa-4,7,10,13,17,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z,16E,18E)-20-Hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine

(4Z,7Z,10Z,13Z,16E,18E)-20-Hydroxydocosa-4,7,10,13,16,18-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(5Z,7Z,10Z,13Z,16Z,19Z)-4-Hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine

(5Z,7Z,10Z,13Z,16Z,19Z)-4-Hydroxydocosa-5,7,10,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,8Z,10Z,13Z,16Z,19Z)-7-Hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine

(4Z,8Z,10Z,13Z,16Z,19Z)-7-Hydroxydocosa-4,8,10,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4E,6E,10Z,13Z,16Z,19Z)-8-Hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine

(4E,6E,10Z,13Z,16Z,19Z)-8-Hydroxydocosa-4,6,10,13,16,19-hexaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z,16Z)-18-(3-Ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine

(4Z,7Z,10Z,13Z,16Z)-18-(3-Ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoylcarnitine

C29H45NO5 (487.32975600000003)


   

(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-Pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine

(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-Pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoylcarnitine

C29H45NO5 (487.32975600000003)


   

[3-methyl-4-(3-methylphenyl)-1-piperazinyl]-[1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)-4-piperidinyl]methanone

[3-methyl-4-(3-methylphenyl)-1-piperazinyl]-[1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)-4-piperidinyl]methanone

C28H37N7O (487.3059432)


   

(1S)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]-1-[4-(1-hydroxy-2-methylpropan-2-yl)phenyl]butan-1-ol

(1S)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]-1-[4-(1-hydroxy-2-methylpropan-2-yl)phenyl]butan-1-ol

C32H41NO3 (487.3086276)


   

N-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

N-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]oxane-4-carboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7R,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8R)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4R,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(4S,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-5-[cyclopentyl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide

C27H41N3O5 (487.30460560000006)


   

(3R,20R)-20-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyhenicosanoate

(3R,20R)-20-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyhenicosanoate

C27H51O7- (487.3634596)


   

(3R)-21-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyhenicosanoate

(3R)-21-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyhenicosanoate

C27H51O7- (487.3634596)


   

Ldgts 17:0

Ldgts 17:0

C27H53NO6 (487.3872678)


   

Ldgcc 16:1

Ldgcc 16:1

C26H49NO7 (487.35088440000004)


   

HexCer 13:2;2O/6:0

HexCer 13:2;2O/6:0

C25H45NO8 (487.314501)


   

HexCer 15:2;2O/4:0

HexCer 15:2;2O/4:0

C25H45NO8 (487.314501)


   

HexCer 17:2;2O/2:0

HexCer 17:2;2O/2:0

C25H45NO8 (487.314501)


   

HexCer 16:2;2O/3:0

HexCer 16:2;2O/3:0

C25H45NO8 (487.314501)


   

HexCer 14:2;2O/5:0

HexCer 14:2;2O/5:0

C25H45NO8 (487.314501)


   

HexCer 12:2;2O/7:0

HexCer 12:2;2O/7:0

C25H45NO8 (487.314501)


   

2-aminoethyl [2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propyl] hydrogen phosphate

2-aminoethyl [2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propyl] hydrogen phosphate

C25H46NO6P (487.30625860000004)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dodeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dodeca-4,8-diene-1-sulfonic acid

C25H45NO6S (487.29674300000005)


   

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]trideca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]trideca-4,8-diene-1-sulfonic acid

C25H45NO6S (487.29674300000005)


   

(4E,8E)-3-hydroxy-2-(undecanoylamino)pentadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(undecanoylamino)pentadeca-4,8-diene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(4E,8E)-3-hydroxy-2-(tridecanoylamino)trideca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(tridecanoylamino)trideca-4,8-diene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(4E,8E)-3-hydroxy-2-(tetradecanoylamino)dodeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(tetradecanoylamino)dodeca-4,8-diene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undec-4-ene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid

(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(4E,8E)-2-(decanoylamino)-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-(decanoylamino)-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(4E,8E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,8-diene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodec-4-ene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydecane-1-sulfonic acid

2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydecane-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridec-4-ene-1-sulfonic acid

C26H49NO5S (487.3331264000001)


   

4-(3-Heptanoyloxy-2-nonanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Heptanoyloxy-2-nonanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C26H49NO7 (487.35088440000004)


   

4-[2,3-Di(octanoyloxy)propoxy]-2-(trimethylazaniumyl)butanoate

4-[2,3-Di(octanoyloxy)propoxy]-2-(trimethylazaniumyl)butanoate

C26H49NO7 (487.35088440000004)


   

4-(3-Propanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Propanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C26H49NO7 (487.35088440000004)


   

4-(3-Butanoyloxy-2-dodecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Butanoyloxy-2-dodecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C26H49NO7 (487.35088440000004)


   

4-(3-Pentanoyloxy-2-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Pentanoyloxy-2-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C26H49NO7 (487.35088440000004)


   

4-(3-Acetyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C26H49NO7 (487.35088440000004)


   

4-(2-Decanoyloxy-3-hexanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Decanoyloxy-3-hexanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C26H49NO7 (487.35088440000004)


   

bhos#38(1-)

bhos#38(1-)

C27H51O7 (487.3634596)


Conjugate base of bhos#38

   

bhas#38(1-)

bhas#38(1-)

C27H51O7 (487.3634596)


Conjugate base of bhas#38

   

NA-Cit 22:5(7Z,10Z,13Z,16Z,19Z)

NA-Cit 22:5(7Z,10Z,13Z,16Z,19Z)

C28H45N3O4 (487.34098900000004)


   

NA-DOPA 20:2(11Z,14Z)

NA-DOPA 20:2(11Z,14Z)

C29H45NO5 (487.32975600000003)


   

CAR 22:6;OH

CAR 22:6;OH

C29H45NO5 (487.32975600000003)


   

MGCC 16:1

MGCC 16:1

C26H49NO7 (487.35088440000004)


   

MGTS 17:0

MGTS 17:0

C27H53NO6 (487.3872678)


   

ST 26:4;O4;Gly

ST 26:4;O4;Gly

C28H41NO6 (487.29337260000005)


   

ST 27:3;O3;Gly

ST 27:3;O3;Gly

C29H45NO5 (487.32975600000003)


   

ST 28:2;O2;Gly

ST 28:2;O2;Gly

C30H49NO4 (487.36613940000007)


   

ST 20:3;O;HexNAc

ST 20:3;O;HexNAc

C28H41NO6 (487.29337260000005)


   

ST 23:0;O3;Tau

ST 23:0;O3;Tau

C25H45NO6S (487.29674300000005)


   

(1s,2r,5s,7r,8r,11s,14s)-1,2-dimethyl-18-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

(1s,2r,5s,7r,8r,11s,14s)-1,2-dimethyl-18-(3-methylbut-2-en-1-yl)-7-(prop-1-en-2-yl)-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaene-8,11-diol

C32H41NO3 (487.3086276)


   

[6-(2-{2-[5-(6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl)-3-methylhexa-1,4-dien-1-yl]-3-methylcyclopropyl}ethenyl)-5-hydroxy-4-(methylamino)oxan-2-yl]acetic acid

[6-(2-{2-[5-(6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl)-3-methylhexa-1,4-dien-1-yl]-3-methylcyclopropyl}ethenyl)-5-hydroxy-4-(methylamino)oxan-2-yl]acetic acid

C29H45NO5 (487.32975600000003)


   

(1s,4s,10s,12s)-12-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

(1s,4s,10s,12s)-12-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

C31H41N3O2 (487.3198606)